Latest Breaking News On - Inc mark namaroff - Page 1 : comparemela.com

Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024

Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesArthrosurface joint solutionsAnika therapeuticsAnika therapeutics incAnika therapeutics inc mark namaroffRegenerative solutionsCorporate communicationsInvestor relationsOsteoarthritis pain managementSports medicineInvestor inquiriesInc mark namaroff

Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs

Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesGreenoughchristine williamsonCherylr blanchardTimothy coddChristopher bakerAnikaanika therapeutics incAnika therapeutics inc mark namaroffUniversity of maryland stAnika therapeuticsAnika therapeutics incSecurities exchangeJoseph medical centerCorporate communicationsArthrosurface joint solutionsRegenerative solutionsFlorida orthopedic institute

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAnika therapeuticsAnikaanika therapeutics incAnika therapeutics inc mark namaroffCorporate communicationsAnika therapeutics incNasdaq global select marketClosing priceNasdaq listing ruleAnikaanika therapeuticsInvestor inquiriesInc mark namaroffInvestor relations